From: Expression of GSK-3β in renal allograft tissue and its significance in pathogenesis of chronic allograft dysfunction
n
GSK(%)
GSK(IOD)
Control group
5
17.45 ± 19.63
21757 ± 23765
IF/TA-I group
12
35.48 ± 11.90⋇
52017 ± 23216⋇
IF/TA-II group
11
48.50 ± 16.51⋇⋆
741235 ± 26216⋇
IF/TA-III group
57.80 ± 14.40⋇⋆
94615 ± 33855⋇⋆